In a patient with moderate-to-severe plaque psoriasis taking icotyde (200 mg tablet) each morning on an empty stomach, what is the significance of fatigue and somnolence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Fatigue with Icotyde: A Common but Generally Benign Adverse Effect

Fatigue occurs in approximately 1.0% of patients taking icotyde (200 mg daily) for moderate-to-severe plaque psoriasis, which is only slightly higher than placebo (0.5%), and does not represent a serious safety concern. 1

Clinical Significance

Based on the FDA prescribing information, fatigue with icotyde is:

  • Not listed as a warning or precaution - The drug label does not include fatigue among serious adverse reactions requiring monitoring or dose adjustment 1
  • Low incidence - Affects only 1 in 100 patients, barely exceeding placebo rates
  • Not associated with serious outcomes - No relationship to infections, immunosuppression, or other major safety signals

Notably, somnolence is not listed as an adverse reaction in the icotyde prescribing information at all, suggesting it either does not occur or occurs at rates indistinguishable from placebo 1.

Clinical Context: Fatigue in Psoriasis

It's important to recognize that fatigue is inherently common in psoriasis patients independent of treatment:

  • Fatigue is a substantial symptom of psoriasis itself, triggered by inflammatory cytokines and psychological factors 2
  • Biological therapies for psoriasis generally improve fatigue through disease control, with a small-to-moderate beneficial effect (standardized mean difference -0.40) 3
  • Icotyde, as an IL-23 receptor antagonist, would be expected to reduce rather than worsen fatigue through its anti-inflammatory effects

Management Approach

When a patient on icotyde reports fatigue:

  1. Do not automatically attribute it to the medication - Consider that baseline fatigue prevalence in psoriasis is high
  2. Assess for alternative causes:
    • Disease activity (inadequate psoriasis control)
    • Depression/anxiety (common comorbidities in psoriasis) 4
    • Sleep disorders
    • Metabolic factors (thyroid dysfunction, anemia)
    • Other medications
  3. Continue icotyde - The low incidence and lack of serious safety signals do not warrant discontinuation
  4. Monitor for improvement - As psoriasis improves with treatment, fatigue often decreases 5, 3

Key Caveat

Do not confuse fatigue with signs of serious infection. While fatigue itself is benign, icotyde does carry warnings about increased infection risk (though serious infections occurred in only 0.2% vs 0.4% placebo) 1. If fatigue is accompanied by fever, persistent cough, or other infectious symptoms, evaluate for clinically important infection and consider holding icotyde until resolved.

The timing of administration (upon waking, empty stomach) 1 should not contribute to somnolence, as the drug is taken in the morning rather than evening.

References

Related Questions

In a 35-year-old African American woman with a prolonged history of abnormal complete blood counts, should I be tested for sickle cell disease or trait?
What is the appropriate treatment for a urinary tract infection (UTI) with nitrofurantoin sensitivity in a patient allergic to sulfonamides and ciprofloxacin?
What is the appropriate treatment for persistent belching in a 50-year-old patient after gastroenteritis?
For a patient with severe dementia who is wandering at night while taking risperidone 0.25 mg oral tablet, what additional medication should be added to manage nighttime wandering?
How should I evaluate and treat a 16-year-old female with anemia, low hematocrit, microcytic anemia, and elevated red cell distribution width, who is obese and has a long history of consuming large amounts of cornstarch?
Can doxepin be used concurrently with warfarin (Coumadin)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.